Diyabetik Santral Sinir Sistemi Komplikasyonları
Özet
Diyabet, merkezi sinir sistemi üzerinde ciddi iskemik, dejeneratif ve akut metabolik komplikasyonlara yol açan epidemik bir hastalıktır. Kronik süreçte mikrovasküler ve makrovasküler hasarlar neticesinde iskemik ve hemorajik inme riskini belirgin şekilde artırır, laküner enfarktlar ile prognozu olumsuz etkiler. Ayrıca, glisemik kontrol bozukluğu, oksidatif stres ve insülin direnci gibi mekanizmalarla Alzheimer ve vasküler demans başta olmak üzere hafif bilişsel bozukluktan demansa uzanan geniş bir yelpazede nörobilişsel yıkıma ve serebral atrofiye neden olur. Akut dönemde ise diyabetik ketoasidoz ve hiperglisemik hiperosmolar koma gibi hayati tehdit eden hiperglisemik aciller fokal nöbetler, ensefalopati ve koreoatetoz gibi ağır nörolojik tabloları tetikler. Diğer taraftan, tedavi komplikasyonu olarak gelişen şiddetli hipoglisemi atakları, özellikle korpus kallozum ve korteks gibi bölgelerde sitotoksik ödeme yol açarak bilişsel fonksiyonları kalıcı olarak bozabilir, epileptik nöbetleri ve inme benzeri semptomları uyarabilir. Bu nedenle, vasküler risk faktörlerinin kontrolü ve kademeli glukoz regülasyonu diyabetik santral sinir sistemi hasarını önlemede kritik öneme sahiptir.
Diabetes is an epidemic disease leading to severe ischemic, degenerative, and acute metabolic complications in the central nervous system. In the chronic phase, microvascular and macrovascular damages significantly increase ischemic and hemorrhagic stroke risks and negatively affect prognosis through lacunar infarcts. Additionally, mechanisms like poor glycemic control, oxidative stress, and insulin resistance cause neurocognitive decline ranging from mild cognitive impairment to dementia, particularly Alzheimer's and vascular dementia, along with cerebral atrophy. In the acute phase, life-threatening hyperglycemic emergencies, such as diabetic ketoacidosis and hyperglycemic hyperosmolar state, trigger severe neurological conditions including focal seizures, encephalopathy, and choreoathetosis. Conversely, severe hypoglycemic episodes occurring as a treatment complication cause cytotoxic edema in regions like the corpus callosum and cortex, potentially permanently impairing cognitive functions while inducing epileptic seizures and stroke-mimicking symptoms. Therefore, managing vascular risk factors and gradual glucose regulation are critical in preventing diabetic central nervous system damage.
Referanslar
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.https://doi.org/10.1016/j.diabres.2021.109119
Standards of Medical Care in Diabetes-2021 Abridged for Primary Care Providers. Clin Diabetes. 2021;39(1):14-43.https://doi.org/10.2337/cd21-as01
Scheen AJ. Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia. Diabetes Metab. 2010;36 Suppl 3:S31-8.https://doi.org/10.1016/S1262-3636(10)70464-X
Roh E, Song DK, Kim MS. Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism. Exp Mol Med. 2016;48:e216.https://doi.org/10.1038/emm.2016.4
King A, Gottlieb E. Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective. Curr Opin Cell Biol. 2009;21(6):885-93.https://doi.org/10.1016/j.ceb.2009.09.009
Luna R, Talanki Manjunatha R, Bollu B, et al. A Comprehensive Review of Neuronal Changes in Diabetics. Cureus. 2021;13(10):e19142.https://doi.org/10.7759/cureus.19142
O'Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761-75.https://doi.org/10.1016/S0140-6736(16)30506-2
O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-23.https://doi.org/10.1016/S0140-6736(10)60834-3
Emerging Risk Factors C, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-22.https://doi.org/10.1016/S0140-6736(10)60484-9
Cui R, Iso H, Yamagishi K, et al. Diabetes mellitus and risk of stroke and its subtypes among Japanese: the Japan public health center study. Stroke. 2011;42(9):2611-4.https://doi.org/10.1161/strokeaha.111.614313
Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014;383(9933):1973-80.https://doi.org/10.1016/s0140-6736(14)60040-4
Khoury JC, Kleindorfer D, Alwell K, et al. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke. 2013;44(6):1500-4.https://doi.org/10.1161/STROKEAHA.113.001318
Cho YR, Ann SH, Won KB, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep. 2019;9(1):6129.https://doi.org/10.1038/s41598-019-42700-1
Dandona P, James IM, Newbury PA, et al. Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br Med J. 1978;2(6133):325-6.https://doi.org/10.1136/bmj.2.6133.325
Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, et al. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004;62(9):1558-62.https://doi.org/10.1212/01.wnl.0000123252.55688.05
Rutten-Jacobs LCA, Markus HS. Vascular Risk Factor Profiles Differ Between Magnetic Resonance Imaging-Defined Subtypes of Younger-Onset Lacunar Stroke. Stroke. 2017;48(9):2405-11.https://doi.org/10.1161/strokeaha.117.017813
Song EC, Chu K, Jeong SW, et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke. 2003;34(9):2215-20.https://doi.org/10.1161/01.STR.0000088060.83709.2C
Szlachetka WA, Pana TA, Tiamkao S, et al. Impact of Diabetes on Complications, Long Term Mortality and Recurrence in 608,890 Hospitalised Patients with Stroke. Glob Heart. 2020;15(1):2.https://doi.org/10.5334/gh.364
Echouffo-Tcheugui JB, Xu H, Matsouaka RA, et al. Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke. Eur Heart J. 2018;39(25):2376-86.https://doi.org/10.1093/eurheartj/ehy036
Shang Y, Fratiglioni L, Marseglia A, et al. Association of diabetes with stroke and post-stroke dementia: A population-based cohort study. Alzheimers Dement. 2020;16(7):1003-12.https://doi.org/10.1002/alz.12101
Jauch EC, Saver JL, Adams HP, Jr., et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870-947.https://doi.org/10.1161/STR.0b013e318284056a
European Stroke Initiative Executive C, Committee EW, Olsen TS, et al. European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis. 2003;16(4):311-37.https://doi.org/10.1159/000072554
Zheng D, Zhao X. Intensive Versus Standard Glucose Control in Patients with Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. World Neurosurg. 2020;136:e487-e95.https://doi.org/10.1016/j.wneu.2020.01.042
Bellolio MF, Gilmore RM, Ganti L. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev. 2014(1):CD005346.https://doi.org/10.1002/14651858.CD005346.pub4
Pandolfi A, Giaccari A, Cilli C, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol. 2001;38(2):71-6.https://doi.org/10.1007/s005920170016
Kamalesh M, Shen J, Eckert GJ. Long term postischemic stroke mortality in diabetes: a veteran cohort analysis. Stroke. 2008;39(10):2727-31.https://doi.org/10.1161/STROKEAHA.108.517441
Cao W, Ling Y, Wu F, et al. Higher fasting glucose next day after intravenous thrombolysis is independently associated with poor outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2015;24(1):100-3.https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.07.029
Nikneshan D, Raptis R, Pongmoragot J, et al. Predicting clinical outcomes and response to thrombolysis in acute stroke patients with diabetes. Diabetes Care. 2013;36(7):2041-7.https://doi.org/10.2337/dc12-2095
Parlani G, De Rango P, Cieri E, et al. Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy. J Vasc Surg. 2012;55(1):79-89; discussion 8-9.https://doi.org/10.1016/j.jvs.2011.07.080
Bell DSH, Goncalves E. Stroke in the patient with diabetes (Part 2) - Prevention and the effects of glucose lowering therapies. Diabetes Res Clin Pract. 2020;164:108199.https://doi.org/10.1016/j.diabres.2020.108199
Gerstein HC, Hart R, Colhoun HM, et al. The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial. Lancet Diabetes Endocrinol. 2020;8(2):106-14.https://doi.org/10.1016/s2213-8587(19)30423-1
Al Hamed FA, Elewa H. Potential Therapeutic Effects of Sodium Glucose-linked Cotransporter 2 Inhibitors in Stroke. Clin Ther. 2020;42(11):e242-e9.https://doi.org/10.1016/j.clinthera.2020.09.008
Gaudet AD, Fonken LK, Watkins LR, et al. MicroRNAs: Roles in Regulating Neuroinflammation. Neuroscientist. 2018;24(3):221-45.https://doi.org/10.1177/1073858417721150
Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci. 2015;1353:60-71.https://doi.org/10.1111/nyas.12807
Toth C. Diabetes and neurodegeneration in the brain. Handb Clin Neurol. 2014;126:489-511.https://doi.org/10.1016/B978-0-444-53480-4.00035-7
Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease. Diabetes Res Clin Pract. 2017;124:41-7.https://doi.org/10.1016/j.diabres.2016.10.024
LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(5):1520-74.https://doi.org/10.1210/jc.2019-00198
Bunn F, Burn AM, Goodman C, et al. Comorbidity and dementia: a scoping review of the literature. BMC Med. 2014;12:192.https://doi.org/10.1186/s12916-014-0192-4
Palta P, Schneider AL, Biessels GJ, et al. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20(3):278-91.https://doi.org/10.1017/S1355617713001483
Bandosz P, Ahmadi-Abhari S, Guzman-Castillo M, et al. Potential impact of diabetes prevention on mortality and future burden of dementia and disability: a modelling study. Diabetologia. 2020;63(1):104-15.https://doi.org/10.1007/s00125-019-05015-4
Dejong R. N.. The nervous system complications of diabetes mellitus wsrtccJNMD.
Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591-604.https://doi.org/10.1038/s41574-018-0048-7
Umegaki H. Neurodegeneration in diabetes mellitus. Adv Exp Med Biol. 2012;724:258-65.https://doi.org/10.1007/978-1-4614-0653-2_19
Rivera EJ, Goldin A, Fulmer N, et al. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J Alzheimers Dis. 2005;8(3):247-68.https://doi.org/10.3233/jad-2005-8304
Koekkoek PS, Kappelle LJ, van den Berg E, et al. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14(3):329-40.https://doi.org/10.1016/S1474-4422(14)70249-2
Cheng G, Huang C, Deng H, et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42(5):484-91.https://doi.org/10.1111/j.1445-5994.2012.02758.x
Thal DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol. 2012;47(11):816-24.https://doi.org/10.1016/j.exger.2012.05.023
Peila R, Rodriguez BL, Launer LJ, et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002;51(4):1256-62.https://doi.org/10.2337/diabetes.51.4.1256
Gotz J, Lim YA, Eckert A. Lessons from two prevalent amyloidoses-what amylin and Abeta have in common. Front Aging Neurosci. 2013;5:38.https://doi.org/10.3389/fnagi.2013.00038
Brundel M, Kappelle LJ, Biessels GJ. Brain imaging in type 2 diabetes. Eur Neuropsychopharmacol. 2014;24(12):1967-81.https://doi.org/10.1016/j.euroneuro.2014.01.023
Manschot SM, Brands AM, van der Grond J, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55(4):1106-13.https://doi.org/10.2337/diabetes.55.04.06.db05-1323
Moran C, Phan TG, Chen J, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care. 2013;36(12):4036-42.https://doi.org/10.2337/dc13-0143
Damanik J, Yunir E. Type 2 Diabetes Mellitus and Cognitive Impairment. Acta Med Indones. 2021;53(2):213-20
Biessels GJ, Janssen J, van den Berg E, et al. Rationale and design of the CAROLINA(R) - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus. BMC Neurol. 2018;18(1):7.https://doi.org/10.1186/s12883-018-1014-7
Biessels GJ, Nobili F, Teunissen CE, et al. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol. 2020;19(8):699-710.https://doi.org/10.1016/S1474-4422(20)30139-3
Geijselaers SLC, Sep SJS, Stehouwer CDA, et al. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet Diabetes Endocrinol. 2015;3(1):75-89.https://doi.org/10.1016/S2213-8587(14)70148-2
Yaffe K, Falvey CM, Hamilton N, et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med. 2013;173(14):1300-6.https://doi.org/10.1001/jamainternmed.2013.6176
Feinkohl I, Price JF, Strachan MW, et al. The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimers Res Ther. 2015;7(1):46.https://doi.org/10.1186/s13195-015-0130-5
Rama Chandran S, Jacob P, Choudhary P. A systematic review of the effect of prior hypoglycaemia on cognitive function in type 1 diabetes. Ther Adv Endocrinol Metab. 2020;11:2042018820906017.https://doi.org/10.1177/2042018820906017
Dafoulas GE, Toulis KA, McCorry D, et al. Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study. Diabetologia. 2017;60(2):258-61.https://doi.org/10.1007/s00125-016-4142-x
Li CC, Chang CC, Cherng YG, et al. Risk and outcomes of diabetes in patients with epilepsy. Sci Rep. 2021;11(1):18888.https://doi.org/10.1038/s41598-021-98340-x
Labandeira CM, Fraga-Bau A, Arias Ron D, et al. Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists. Front Neuroendocrinol. 2021;62:100914.https://doi.org/10.1016/j.yfrne.2021.100914
Montojo MT, Aganzo M, Gonzalez N. Huntington's Disease and Diabetes: Chronological Sequence of its Association. J Huntingtons Dis. 2017;6(3):179-88.https://doi.org/10.3233/JHD-170253
Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Med Clin North Am. 2017;101(3):587-606.https://doi.org/10.1016/j.mcna.2016.12.011
Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. Bmj. 2019;365:l1114.https://doi.org/10.1136/bmj.l1114
Wei Y, Wu C, Su F, et al. Clinical characteristics and outcomes of patients with diabetic ketoacidosis of different severity. Medicine (Baltimore). 2020;99(45):e22838.https://doi.org/10.1097/md.0000000000022838
Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract. 2011;94(3):340-51.https://doi.org/10.1016/j.diabres.2011.09.012
Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study. Diabetes Care. 2018;41(9):1870-7.https://doi.org/10.2337/dc17-1583
Eledrisi MS, Elzouki AN. Management of Diabetic Ketoacidosis in Adults: A Narrative Review. Saudi J Med Med Sci. 2020;8(3):165-73.https://doi.org/10.4103/sjmms.sjmms_478_19
Scott AR, Joint British Diabetes Societies for Inpatient C, group Jhhg. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med. 2015;32(6):714-24.https://doi.org/10.1111/dme.12757
Cruz-Flores S. Neurological Complications of Endocrine Emergencies. Curr Neurol Neurosci Rep. 2021;21(5):21.https://doi.org/10.1007/s11910-021-01105-2
Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24(1):131-53.https://doi.org/10.2337/diacare.24.1.131
Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism. 2016;65(4):507-21.https://doi.org/10.1016/j.metabol.2015.12.007
Maletkovic J, Drexler A. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Endocrinol Metab Clin North Am. 2013;42(4):677-95.https://doi.org/10.1016/j.ecl.2013.07.001
Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014;37(11):3124-31.https://doi.org/10.2337/dc14-0984
Maccario M. Neurological dysfunction associated with nonketotic hyperglycemia. Arch Neurol. 1968;19(5):525-34.https://doi.org/10.1001/archneur.1968.00480050095009
Chung SJ, Lee JH, Lee SA, et al. Co-occurrence of seizure and chorea in a patient with nonketotic hyperglycemia. Eur Neurol. 2005;54(4):230-2.https://doi.org/10.1159/000090717
Hwang KJ, Yoon S, Park KC. Non-ketotic hyperglycaemia presenting as epilepsia partialis continua. Epileptic Disord. 2016;18(2):201-3.https://doi.org/10.1684/epd.2016.0833
Cokar O, Aydin B, Ozer F. Non-ketotic hyperglycaemia presenting as epilepsia partialis continua. Seizure. 2004;13(4):264-9.https://doi.org/10.1016/S1059-1311(03)00155-9
Peddawad D. Epileptic manifestations, pathophysiology, and imaging characteristics of non-ketotic hyperglycaemia: a review of the literature and a report of two cases with irreversible cortical vision loss. J Int Med Res. 2022;50(3):3000605221081429.https://doi.org/10.1177/03000605221081429
Kim DW, Moon Y, Gee Noh H, et al. Blood-brain barrier disruption is involved in seizure and hemianopsia in nonketotic hyperglycemia. Neurologist. 2011;17(3):164-6.https://doi.org/10.1097/NRL.0b013e3182173528
Ahlskog JE, Nishino H, Evidente VG, et al. Persistent chorea triggered by hyperglycemic crisis in diabetics. Mov Disord. 2001;16(5):890-8.https://doi.org/10.1002/mds.1171
Moien-Afshari F, Téllez-Zenteno JF. Occipital seizures induced by hyperglycemia: a case report and review of literature. Seizure. 2009;18(5):382-5.https://doi.org/10.1016/j.seizure.2008.12.001
Seo DW, Na DG, Na DL, et al. Subcortical hypointensity in partial status epilepticus associated with nonketotic hyperglycemia. J Neuroimaging. 2003;13(3):259-63
Chu K, Kang DW, Kim DE, et al. Diffusion-weighted and gradient echo magnetic resonance findings of hemichorea-hemiballismus associated with diabetic hyperglycemia: a hyperviscosity syndrome? Arch Neurol. 2002;59(3):448-52.https://doi.org/10.1001/archneur.59.3.448
Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222-32.https://doi.org/10.1038/nrendo.2016.15
Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, et al. Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Curr Diab Rep. 2018;18(8):53.https://doi.org/10.1007/s11892-018-1018-0
Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol. 2014;10(12):711-22.https://doi.org/10.1038/nrendo.2014.170
Yong AW, Morris Z, Shuler K, et al. Acute symptomatic hypoglycaemia mimicking ischaemic stroke on imaging: a systemic review. BMC Neurol. 2012;12:139.https://doi.org/10.1186/1471-2377-12-139
Monami M, Mannucci E, Breschi A, et al. Seizures as the only clinical manifestation of reactive hypoglycemia: a case report. J Endocrinol Invest. 2005;28(10):940-1.https://doi.org/10.1007/BF03345327
Blaabjerg L, Juhl CB. Hypoglycemia-Induced Changes in the Electroencephalogram: An Overview. J Diabetes Sci Technol. 2016;10(6):1259-67.https://doi.org/10.1177/1932296816659744
Neyal M.Sinir Sistemi’nin Edinsel Nutrisyonel Metabolik Endokrin Hastalıkları.In: Emre M: Güneş Tıp Kitabevi, 2013. p.1157-1189
Nguyen LB, Nguyen AV, Ling SH, et al. Analyzing EEG signals under insulin-induced hypoglycemia in type 1 diabetes patients. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:1980-3.https://doi.org/10.1109/EMBC.2013.6609917
Kang EG, Jeon SJ, Choi SS, et al. Diffusion MR imaging of hypoglycemic encephalopathy. AJNR Am J Neuroradiol. 2010;31(3):559-64.https://doi.org/10.3174/ajnr.A1856
Schmidt P, Bottcher J, Ragoschke-Schumm A, et al. Diffusion-weighted imaging of hyperacute cerebral hypoglycemia. AJNR Am J Neuroradiol. 2011;32(7):1321-7.https://doi.org/10.3174/ajnr.A2464
